Oncobox was founded by Andrew Garazha, Anton Buzdin.

Who are Oncobox's investors?

Oncobox's investors include Y Combinator, Khosla Ventures.

Where is Oncobox headquartered?

Oncobox is headquartered in Walnut, US.

Oncobox

YC S17

Walnut, US · 11 employees · 2 known investors

Find your way into Oncobox

Paths you didn't know you had: your email and LinkedIn already hold routes to the Oncobox team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.

Also known as OmicsWay, Inc. · Oncobox, OncoBox

Digital Health Healthtech Medical Devices Drug discovery OncologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S17)

Andrew Garazha Co-founder · Chief Executive OfficerAndrew Garazha is founder and CEO of Oncobox, which performs genetic profiling of tumor samples to identify targeted cancer therapies most likely to be effective for individual patients. He has a background in bioinformatics and precision medicine.

Anton Buzdin Co-founder · CSOAnton Buzdin is founder and Chief Scientific Officer of Oncobox, a cancer diagnostics company that analyzes tumor genetics and molecular pathways to guide oncologists in selecting targeted therapies for advanced cancer patients. He has background in genetics, bioinformatics, and molecular medicine.

Investors · 2

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

Khosla VenturesreportedMenlo Park · $100K – $20M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

OncohealthOncoHealth develops software and services to help health plans, employers, and oncologists manage cancer care and reduce treatment complexity. The platform combines oncology management tools with nursing, mental health, nutrition, and navigation services for patients and health systems.

FidoCureOne Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development. The company leverages a dataset of 2 billion datapoints from dogs with naturally occurring cancer to serve as a comparative model for pharmaceutical R&D, helping drug developers validate efficacy and identify biomarkers before human trials.

Endpoint HealthEndpoint Health develops immunology-focused therapeutics paired with diagnostic tests designed to match individual patients with treatments suited to their biology for critical and chronic illnesses.

OncoLensOncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.

54Gene54Gene conducts genomics research and provides related services to increase the representation of African genetic data in medical research, which aims to advance healthcare solutions globally.

OncoOnco provides cancer patients in India with access to expert oncologists, quality treatment centers, discounted cancer medicines, diagnostic tests, and support throughout their treatment journey. The platform connects patients with specialists, offers curated treatment packages, and provides survivor mentorship and remote answers to cancer-related queries.

Eris BiotechEris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.

OneOncologyOneOncology invests in and partners with community oncology practices to deliver cancer care, helping them grow, diversify across specialties, and apply data and technology to improve performance. It operates a network of oncology and urology practices across the United States.

Velorum TherapeuticsVelorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.

OncOnc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.

Companies working in the same space as Oncobox.

Legal entities · 1

corporate structure

OmicsWay, Inc.

Frequently asked questions

What does Oncobox do?: Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.
Who founded Oncobox?: Oncobox was founded by Andrew Garazha, Anton Buzdin.
Who are Oncobox's investors?: Oncobox's investors include Y Combinator, Khosla Ventures.
Where is Oncobox headquartered?: Oncobox is headquartered in Walnut, US.